Catalyst Wire Dossier Catalyst Wire Dossier

SPL7013 Gel (VivaGel)

spl7013 gel · Starpharma Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPL7013 Gel (VivaGel), covering 2019-07-09 to 2019-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis [Phase 3]

See pricing